UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Antiviral research, ISSN 0166-3542, 07/2017, Volume 143, pp. 230 - 236
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Mycophenolic Acid - antagonists & inhibitors | Zika Virus Infection - drug therapy | Cytopathogenic Effect, Viral - drug effects | DNA Replication - drug effects | Cercopithecus aethiops | Glycosylation - drug effects | Virus Internalization - drug effects | Suramin - administration & dosage | Suramin - antagonists & inhibitors | Zika Virus Infection - virology | Time Factors | Flavivirus - drug effects | Mycophenolic Acid - administration & dosage | Vero Cells | Virus Replication - drug effects | Zika Virus - growth & development | RNA, Viral - biosynthesis | Zika Virus - physiology | RNA, Viral - analysis | Zika Virus - drug effects | Virion - drug effects | Virus Attachment - drug effects | Virus Release - drug effects | Animals | RNA, Viral - drug effects | Birth defects | Conjunctivitis | Microbiology | RNA | Guillain-Barre syndrome | Index Medicus
Journal Article
2.
Full Text
RAGE-aptamer blocks the development and progression of experimental diabetic nephropathy
Diabetes (New York, N.Y.), ISSN 0012-1797, 06/2017, Volume 66, Issue 6, pp. 1683 - 1695
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Rats, Wistar | Humans | NADPH Oxidases - metabolism | Male | Receptor for Advanced Glycation End Products - antagonists & inhibitors | Albuminuria | Mesangial Cells - drug effects | Kidney - metabolism | NADPH Oxidases - drug effects | Receptor for Advanced Glycation End Products - genetics | Diabetes Mellitus, Experimental - metabolism | Real-Time Polymerase Chain Reaction | Aptamers, Nucleotide - pharmacology | Fibrosis - genetics | Kidney - drug effects | Enzyme-Linked Immunosorbent Assay | Diabetic Nephropathies - metabolism | Receptor for Advanced Glycation End Products - metabolism | Rats | Chemokine CCL2 - genetics | Glycation End Products, Advanced - drug effects | Gene Expression Regulation - drug effects | Animals | Podocytes - drug effects | Glycation End Products, Advanced - metabolism | Mesangial Cells - pathology | Inflammation - genetics | Receptor for Advanced Glycation End Products - drug effects | Oxidative Stress - drug effects | Chemokine CCL2 - drug effects | Oxidative stress | Development and progression | Research | Streptozocin | Diabetic nephropathies | Advanced glycosylation end products | Kidneys | Peptides | Diabetes mellitus | Glycosylation | Inflammation | Macrophages | Experiments | NAD(P)H oxidase | Molecules | Nephropathy | Rodents | Aptamers | Mesangial cells | Extracellular matrix | Diabetes | Kidney diseases | Monocyte chemoattractant protein 1 | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Cell stem cell, ISSN 1934-5909, 07/2012, Volume 11, Issue 1, pp. 62 - 74
Cell & Tissue Engineering | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Cell physiology | Molecular and cellular biology | Cell differentiation, maturation, development, hematopoiesis | Embryonic Stem Cells - metabolism | Transcription, Genetic - drug effects | Embryonic Stem Cells - cytology | Humans | Molecular Sequence Data | Gene Regulatory Networks - drug effects | Glycosylation - drug effects | SOXB1 Transcription Factors - metabolism | Octamer Transcription Factor-3 - genetics | Cell Differentiation - genetics | Cellular Reprogramming - genetics | Amino Acid Sequence | Octamer Transcription Factor-3 - chemistry | Mice, Inbred C57BL | Gene Expression Regulation, Developmental - drug effects | Acetylglucosamine - pharmacology | Mutation - genetics | Acetylglucosamine - chemistry | Cellular Reprogramming - drug effects | Pluripotent Stem Cells - metabolism | Animals | Cell Differentiation - drug effects | Models, Biological | Octamer Transcription Factor-3 - metabolism | Pluripotent Stem Cells - drug effects | Cell Proliferation - drug effects | Mice | Index Medicus
Journal Article
Cell proliferation, ISSN 0960-7722, 10/2018, Volume 51, Issue 5, pp. e12471 - n/a
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Adipogenesis - drug effects | Osteoporosis - drug therapy | Receptor for Advanced Glycation End Products - antagonists & inhibitors | Adipocytes - drug effects | Bone and Bones - drug effects | Adipose Tissue - metabolism | Osteoporosis - metabolism | Bone and Bones - metabolism | Female | Cell Differentiation - physiology | Adult Stem Cells - drug effects | Bone Regeneration - drug effects | Osteogenesis - drug effects | Cells, Cultured | Diabetes Mellitus - drug therapy | Diabetes Mellitus - metabolism | Rats | Glycogen Synthase Kinase 3 beta - metabolism | Rats, Sprague-Dawley | Up-Regulation - drug effects | Adult Stem Cells - metabolism | Animals | Wnt Signaling Pathway - drug effects | Glycation End Products, Advanced - pharmacology | Adipocytes - metabolism | Adipose Tissue - drug effects | DNA Methylation - drug effects | Osteoporosis | Methyltransferases | Methylation | DNA | Stem cells | Wnt protein | Differentiation (biology) | Alizarin | Western blotting | Signal transduction | Receptors | Bone growth | Mineralization | DNA methylation | Bones | Biocompatibility | Age | Deoxyribonucleic acid--DNA | Cbfa-1 protein | Advanced glycosylation end products | Tissue engineering | Diabetes mellitus | DNMT1 protein | Glycosylation | Regeneration | Signaling | Inhibitors | Biomarkers | Diabetes | Immunofluorescence | Osteogenesis | Index Medicus
Journal Article
Cardiovascular diabetology, ISSN 1475-2840, 07/2018, Volume 17, Issue 1, pp. 108 - 108
SGLT2 | RECK | Vascular stiffness | Renal resistivity | Pulsatility index | Cardiac & Cardiovascular Systems | Endocrinology & Metabolism | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Kidney - blood supply | Kidney - pathology | Diabetic Nephropathies - etiology | Diabetes Mellitus, Type 2 - genetics | Humans | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Diabetic Angiopathies - etiology | Endothelium, Vascular - drug effects | Glycosuria - etiology | Diabetic Angiopathies - physiopathology | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Glycosuria - prevention & control | Pulsatile Flow - drug effects | Mice, Mutant Strains | Vascular Resistance - drug effects | Female | Renal Circulation - drug effects | Diabetic Angiopathies - prevention & control | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Disease Models, Animal | Cell Line | Diabetic Nephropathies - pathology | Glucosides - pharmacology | Kidney - drug effects | Albuminuria - etiology | Sodium-Glucose Transporter 2 - metabolism | Mice, Inbred C57BL | Endothelium, Vascular - physiopathology | Albuminuria - prevention & control | GPI-Linked Proteins - metabolism | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Animals | Endothelium, Vascular - metabolism | Vascular Stiffness - drug effects | Benzhydryl Compounds - pharmacology | Vasodilation - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Renal artery | Control methods | Glucose | Proximal tubules | Vasodilation | Risk factors | Proteins | Hyperglycemia | Reversion | Rodents | Aorta | Blood pressure | Stiffness | Diabetes mellitus (non-insulin dependent) | Hypertension | Glucose transporter | Advanced glycosylation end products | Kidneys | Diabetes mellitus | Health risks | Reabsorption | Glycosylation | Risk analysis | Investigations | Nitric-oxide synthase | Endothelial cells | Endothelium | Weight control | Inhibitors | Sodium | Electrical resistivity | Nitric oxide | Fibrosis | Mice | Diabetes | Kidney diseases | Cardiovascular diseases | Transporter | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 02/2012, Volume 482, Issue 7384, pp. 232 - 236
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Physicochemical properties. Structure-activity relationships | General pharmacology | Pharmacology. Drug treatments | Biological and medical sciences | Antiparasitic agents | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Lysosomes - drug effects | Trypanosomiasis, African - drug therapy | Melarsoprol - pharmacology | Trypanosoma brucei brucei - metabolism | Endocytosis - drug effects | Humans | Trypanosoma brucei brucei - cytology | Eflornithine - pharmacology | Glycosylation - drug effects | Trypanosoma brucei brucei - enzymology | Trypanosoma brucei brucei - drug effects | Drug Resistance - genetics | Nifurtimox - pharmacology | High-Throughput Screening Assays | Lysosomes - metabolism | RNA Interference | Trypanocidal Agents - pharmacology | Aquaglyceroporins - deficiency | Trypanocidal Agents - therapeutic use | Trypanosomiasis, African - genetics | Suramin - pharmacology | Aquaglyceroporins - metabolism | Pentamidine - pharmacology | Chemotherapy | Care and treatment | Research | Drug resistance | Health aspects | Trypanosomiasis | Cancer | Proteins | Studies | Toxicity | Genomes | Biosynthesis | Genetic testing | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Plant and cell physiology, ISSN 0032-0781, 01/2014, Volume 55, Issue 1, pp. 218 - 228
Plant hormone | Auxin | Metabolism | Arabidopsis | Glucosyltransferase | Life Sciences & Biomedicine | Plant Sciences | Science & Technology | Cell Biology | Arabidopsis - enzymology | Plant Roots - genetics | Glycosylation - drug effects | Indoleacetic Acids - chemistry | Plant Roots - drug effects | Arabidopsis Proteins - metabolism | Plant Roots - physiology | Glucosyltransferases - metabolism | Biosynthetic Pathways - genetics | Biocatalysis - drug effects | Enzyme Induction - drug effects | Gravitropism - drug effects | Glycosyltransferases - biosynthesis | Glucosyltransferases - genetics | Arabidopsis Proteins - genetics | Arabidopsis - drug effects | Indoleacetic Acids - metabolism | Arabidopsis - genetics | Gene Expression Regulation, Plant - drug effects | Metabolic Networks and Pathways - genetics | Biosynthetic Pathways - drug effects | Genes, Plant - genetics | Indoleacetic Acids - pharmacology | Kinetics | Metabolic Networks and Pathways - drug effects | Index Medicus | Regular Papers
Journal Article
Brain (London, England : 1878), ISSN 0006-8950, 05/2017, Volume 140, Issue 5, pp. 1399 - 1419
glycation | neurodegeneration | Parkinson's disease | alpha-synuclein | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | alpha-Synuclein - physiology | Male | Hippocampus - drug effects | Glycosylation - drug effects | alpha-Synuclein - drug effects | Yeasts - physiology | Female | Cell Survival - physiology | Disease Models, Animal | Cell Survival - drug effects | Pyruvaldehyde - pharmacology | Induced Pluripotent Stem Cells - drug effects | Induced Pluripotent Stem Cells - physiology | alpha-Synuclein - toxicity | Drosophila | Cells, Cultured | Enzyme Inhibitors - pharmacology | Rats | Mice, Transgenic | Neurodegenerative Diseases - metabolism | Yeasts - drug effects | Animals | Cell Differentiation - drug effects | Mice | Protein Processing, Post-Translational | Hippocampus - physiology | alpha-Synuclein - metabolism | Protein Aggregation, Pathological - metabolism | Aging - metabolism | Index Medicus | Abridged Index Medicus
Journal Article